Victory Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$354K Buy
16,266
+1,191
+8% +$23.1K ﹤0.01% 2095
2025
Q4
$324K Buy
15,075
+1,293
+9% +$27.3K ﹤0.01% 2100
2025
Q3
$266K Sell
13,782
-3,548
-20% -$63.3K ﹤0.01% 2166
2025
Q2
$296K Sell
17,330
-50,382
-74% -$2.15M ﹤0.01% 2164
2025
Q1
$4.32M Sell
67,712
-21,096
-24% -$2.22M ﹤0.01% 1322
2024
Q4
$10.8M Buy
88,808
+22,529
+34% +$2.76M 0.01% 1066
2024
Q3
$8.28M Sell
66,279
-16,794
-20% -$2.32M 0.01% 1162
2024
Q2
$13.1M Buy
83,073
+11,087
+15% +$1.42M 0.01% 978
2024
Q1
$9.32M Sell
71,986
-3,046
-4% -$373K 0.01% 1082
2023
Q4
$7.24M Sell
75,032
-12,354
-14% -$1.19M 0.01% 1157
2023
Q3
$10.6M Buy
87,386
+12,894
+17% +$1.46M 0.01% 992
2023
Q2
$8.53M Sell
74,492
-3,135
-4% -$404K 0.01% 1093
2023
Q1
$10.7M Buy
77,627
+20,350
+36% +$2.64M 0.01% 1005
2022
Q4
$7.42M Sell
57,277
-139,177
-71% -$16.1M 0.01% 1111
2022
Q3
$21.7M Buy
196,454
+160,708
+450% +$16.2M 0.03% 770
2022
Q2
$2.68M Sell
35,746
-17,322
-33% -$1.27M ﹤0.01% 1387
2022
Q1
$4.08M Sell
53,068
-579,212
-92% -$44.4M ﹤0.01% 1326
2021
Q4
$56.9M Buy
632,280
+621,740
+5,899% +$53.2M 0.05% 514
2021
Q3
$975K Buy
10,540
+610
+6% +$47K ﹤0.01% 1873
2021
Q2
$772K Sell
9,930
-134
-1% -$10.2K ﹤0.01% 1987
2021
Q1
$750K Sell
10,064
-19,342
-66% -$1.78M ﹤0.01% 2034
2020
Q4
$5.01M Sell
29,406
-3,502
-11% -$519K 0.01% 1240
2020
Q3
$4.62M Buy
32,908
+21,631
+192% +$3.29M 0.01% 1215
2020
Q2
$1.81M Sell
11,277
-11,571
-51% -$1.57M ﹤0.01% 1472
2020
Q1
$2.23M Buy
22,848
+11,384
+99% +$1.3M ﹤0.01% 1556
2019
Q4
$1.48M Sell
11,464
-286
-2% -$28.9K ﹤0.01% 1611
2019
Q3
$885K Buy
+11,750
New +$1.39M ﹤0.01% 1724

Other funds holding SRPT